期刊文献+

人类免疫缺陷病毒感染者机会性感染的防治 被引量:4

下载PDF
导出
出处 《中国抗感染化疗杂志》 2001年第2期121-124,共4页 Chinese Journal of Infection and Chemotherapy
  • 相关文献

参考文献10

  • 1Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection[J]. N Engl J Med, 1998, 338(13): 853-860.
  • 2Grulich AE. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy[J]. J Acquir Immune Defic Syndr, 1999, 21(Suppl 1): S27-S30.
  • 3Kovacs J, Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection[J]. N Engl J Med, 2000, 342(19): 1416-1429.
  • 4Miller V, Mocroft A, Reiss P, et al. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression:results from the EuroSIDA study[J]. Ann Intern Med, 1999, 130(7): 570-577.
  • 5Nielsen H, Kvinesdal B, Benfield T, et al. Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection[J]. Scand J Infect Dis, 1998, 30(6): 597-601.
  • 6Tasker SA, Treanor JJ, Paxton WB, et al. Efficacy of influenza vaccination in HIV-infceted persons: a randomized ,double-blind, placebo-controlled trial[J]. Ann Intern Med, 1999, 131(6): 430-433.
  • 7Havlir DV, Dube MP, Sattler FR, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabution, or both[J]. N Engl J Med, 1996, 335(6): 392-398.
  • 8McKinsey DS, Wheat LJ, Cloud GA, et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study[J]. Clin Infect Dis, 1999, 28(5): 1049-1056.
  • 9Furrer H, Egger M, Opravil M, et al. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy[J]. N Engl J Med, 1999, 340(17): 1301-1306.
  • 10Kirk O, Lundgren JD, Pedersen C, et al. Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy[J]. AIDS, 1999,13(13): 1647-1651.

同被引文献20

  • 1刘艳,余卫业,王晓燕,乐晓华,李慧涓,胡毅文,王辉,陆普选.艾滋病合并结核病患者的免疫功能临床研究[J].中国防痨杂志,2005,27(1):47-50. 被引量:20
  • 2郜桂菊,张福杰,姚均,赵红心,卢联合,李鑫.HIV感染者/AIDS患者CD_4^+细胞计数与机会性感染对应关系的临床分析[J].中国艾滋病性病,2005,11(4):241-243. 被引量:87
  • 3赵晓梅,吕维柏.311例艾滋病并发皮肤粘膜感染分析及中药治疗[J].中国医药学报,1996,11(2):55-56. 被引量:12
  • 4Kovacs J, Massur H. Prophylaxis against to opportunistic infections inpatients with human immunodeficiency virus infection. N Engl J Med,2000,342(19) :1416-1429.
  • 5Wannamethee SG, Sirivichayakul S, Phillips AN, et al. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Int J Epidemiol,1998,27(2):289-295.
  • 6Miller V, Mocroft A, Reiss P, et al. Relations among CD4 lymphocyte count nadir antiretroviral therapy, and HIV-1 disease progression: results from the euro AIDS study. Ann Intern Med, 1999,130(7) :570- 577.
  • 7Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-assoclated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis, 2000,30 Suppl 1 : S5-14.
  • 8Dore GJ,Hoy JF, Mallal SA, et al. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort. J Acquit Immune Defic Syndr Hum Retrovirol, 1997,16 (1) :39-43.
  • 9Maartens G,Wood R, O' Keefe E, et al. Independent epidemics of heterosexual and homosexual HIV infection in South Africa- survival differences. Q J Med, 1997,90(7) :449- 454.
  • 10Yazdanpanah Y,Chene G, Losina E, et al. Incidence of primary opportunistic infections in two human immunodeficiency virus infected French clinical cohorts. Int J Epidemiol, 2001,30 (4) : 864-871.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部